Marc Schwartz, MD, Neurosurgery, La Jolla, CA, UC San Diego Medical Center – Hillcrest


Neurosurgery La Jolla, CA

Brain & Spinal Tumor, Skull Base, Stereotactic & Functional Neurosurgery

University of California San Diego Neurosurgery

Dr. Schwartz is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schwartz's full profile

Already have an account?

  • Office

    UCSD Neurosurgery Jacobs Medical Center
    9300 Campus Point Drive #7893
    La Jolla, CA 92037
    Phone(858) 657-7920
    Fax(858) 249-0906
  • Is this information wrong?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Neurological Surgery, 1991 - 1997
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Transitional Year, 1991 - 1992
  • Harvard Medical School
    Harvard Medical SchoolClass of 1991
  • Oregon Health & Science University
    Oregon Health & Science UniversityFellowship, Skull Base Surgery

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2022
  • OR State Medical License
    OR State Medical License 1997 - Present
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Young Neurosurgeon Award Council of State Neurosurgical Societies, 2000, 2004
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
  • Fellow (FAANS) American Association of Neurological Surgeons
  • Join now to see all

Publications & Presentations



  • Blinatumomab in Combination with Pembrolizumab Is Safe for Adults with Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia: University of California Hematolo... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • A phase I/II study of blinatumomab in combination with pembrolizumab for adults with relapsed refractory B-lineage acute lymphoblastic leukemia: University of Californ... 
    2019 ASCO Annual Meeting - 6/1/2019

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Consultant, Cochlear Americas